Abstracts

The full collection of abstracts is available now!

Congratulations to our Outstanding Poster Award winners!

Saeed Anwar, University of Alberta
Enhancing Antisense Oligonucleotide Efficacy Using Small Molecule Oligonucleotide Activity Enhancers (OAEs)
Pranali Mistry, Nationwide Children's Hospital
Developing a Second Generation Proviral Plasmid to Reduce Aberrant Cross Packaging and ITR Promoter Activity in AAV Vector Preparations

Important Dates

Abstract Submission Opens	May 1, 2024
Abstract Submission Closes	August 16, 2024
Notifications Sent to Authors	September 9, 2024
Abstracts Released to Public	November 4 @ 4:30 p.m. ET

Abstract Topics

Duchenne Muscular Dystrophy (DMD)
Becker Muscular Dystrophy (BMD)
Limb-Girdle Muscular Dystrophies (LGMD)
Myotonic Dystrophy (DM)
Facioscapulohumeral Muscular Dystrophy (FSHD)
Emery-Dreifuss Muscular Dystrophy (EDMD)
Oculopharyngeal Muscular Dystrophy (OPMD)
Congenital Muscular Dystrophies (CMD)
Congenital Myopathy

Author Registration Discounts

ASGCT members can save up to $200 on registration, and Associate Members (students and postdoctoral fellows) who are first and presenting authors can get a discounted* registration rate of $250! Be sure to register to attend in-person or virtually.

*Discounted rates do not apply if your abstract is withdrawn or rejected.

Embargo Policy

Abstracts will be released on November 4, 2024 at 4:30pm ET.

Researchers and presenters are free to discuss the content of their abstracts throughout this embargo period, but any abstract-related content may not be published until the abstracts are publicly released online. 

Updated data, new graphics, and follow-up information to be presented during oral presentation sessions is embargoed until 6 a.m. on the presentation day. 

Updated data, new graphics, and follow-up information to be presented via ePoster is embargoed until 6 a.m. on the first day of the meeting, November 19.

ASGCT will publish the titles and authors in the abstract collection upon the acceptance of notification on September 9. After an abstract author has accepted their presentation role, the author and their organization are encouraged to publicize the title, author name, and presentation time across any channels they'd like, tagging ASGCT where applicable.